Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations

about

Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations

Item

http://www.wikidata.org/entity/Q57171032

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Using quantitative systems pha ...... tors in therapeutic situations

@en

Using quantitative systems pha ...... tors in therapeutic situations

@nl

type

Item

label

Using quantitative systems pha ...... tors in therapeutic situations

@en

Using quantitative systems pha ...... tors in therapeutic situations

@nl

prefLabel

Using quantitative systems pha ...... tors in therapeutic situations

@en

Using quantitative systems pha ...... tors in therapeutic situations

@nl

P1476

Using quantitative systems pha ...... tors in therapeutic situations

@en

P2093

Brigida Fabry

http://www.w3.org/2001/XMLSchema#string

Christoph Thiel

http://www.w3.org/2001/XMLSchema#string

Henrik Cordes

http://www.w3.org/2001/XMLSchema#string

Ines Smit

http://www.w3.org/2001/XMLSchema#string

Lars Kuepfer

http://www.w3.org/2001/XMLSchema#string

Lars Mathias Blank

http://www.w3.org/2001/XMLSchema#string

Vanessa Baier

http://www.w3.org/2001/XMLSchema#string

P2860

DrugBank: a comprehensive resource for in silico drug discovery and exploration

Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal

The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models

Modeling of rifampicin-induced CYP3A4 activation dynamics for the prediction of clinical drug-drug interactions from in vitro data

Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients.

From PK/PD to QSP: Understanding the Dynamic Effect of Cholesterol-Lowering Drugs on Atherosclerosis Progression and Stratified Medicine.

Using expression data for quantification of active processes in physiologically based pharmacokinetic modeling.

Polypharmacology: drug discovery for the future.

Quantitative systems pharmacology as an extension of PK/PD modeling in CNS research and development.

Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development.

P2888

s41540-018-0062-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41540-018-0062-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30083389

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6072773

http://www.w3.org/2001/XMLSchema#string